Pulmonary Disease Doctors in Middletown, NY Accepting Medicare

6 Pulmonary Disease doctors found. Showing 1 - 6

Dr. Matthew James Michaels, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575    Fax: 845-333-7202

Haitham Nsour, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999    Fax: 845-703-6297

Dr. Janpreet Mokha, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 707 E Main St, Middletown, NY 10940 Phone: 845-333-7575    Fax: 845-333-7202

David Shiu, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 155 Crystal Run Rd, Middletown, NY 10941 Phone: 845-703-6999    Fax: 845-703-6297

Richard Frank Walker, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 90 Crystal Run Rd, Suite 403, Middletown, NY 10941 Phone: 845-703-8806

Maryann Park, M.D Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Maltese Dr, Middletown, NY 10940 Phone: 845-342-4774    Fax: 845-818-7555

News Archive

New photo-switchable molecule for PDT could help treat rapidly growing tumors

Photoswitchable agents might reduce side effects of a chemotherapy. So far, photodynamic therapies have been dependent on oxygen in the tissue. But hardly any oxygen exists in malignant, rapidly growing tumors.

Inflammatory marker may highlight aggressive RCC treatment need

Patients with metastatic renal cell carcinoma who have high preoperative levels of the inflammatory marker C-reactive protein may need intensive multimodal treatment to optimize their survival, say researchers.

UT Southwestern secures $5 million grant for lupus research

The division of rheumatic diseases in the Department of Internal Medicine at UT Southwestern Medical Center has been awarded a five-year, $5 million grant from the National Institutes of Health to fund the Center of Research Translation, which will investigate the autoimmune disease systemic lupus erythematosus (SLE).

FDA clears Soligenix's IND application for SGX942 for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.

FDA report says pharmacy knew about contamination problems

A federal inspection of a company whose tainted pain medicine has caused one of the worst public health drug disasters since the 1930s found greenish-yellow residue on sterilization equipment, surfaces coated with levels of mold and bacteria that exceeded the company's own environmental limits, and an air-conditioner that was shut off nightly despite the importance of controlling temperature and humidity.

Read more Medical News

› Verified 6 days ago